BIT
OPTR

BlackRock Institutional Trust’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

BlackRock Institutional Trust’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,472,312
Closed -$18.5M – 4123
2013
Q3 		$18.5M Buy
1,472,312
+100,401
+7% +$1.33M ﹤0.01% 1918
2013
Q2 		$19.9M Buy
+1,371,911
New +$20M ﹤0.01% 1820

BlackRock Institutional Trust's OPTR Position: Q4 2013 in Review

BlackRock Institutional Trust sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 1,472,312 shares — an estimated $18.5M sold.

BlackRock Institutional Trust first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $19.9M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • BlackRock Institutional Trust reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • BlackRock Institutional Trust sold 1,472,312 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $18.5M.
  • BlackRock Institutional Trust first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • BlackRock Institutional Trust's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $19.9M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on BlackRock Institutional Trust's 13F filing for Q4 2013, filed 12 Feb 2014.